vimarsana.com

Latest Breaking News On - Kenneth micklethwaite - Page 1 : vimarsana.com

Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024

Tim Kelly to lead Caribou’s technical operations strategy and execution CB-010 ANTLER Phase 1 trial initial dose expansion data and RP2D to be disclosed Q2 2024; Caribou plans to initiate.

Sydney
New-south-wales
Australia
Westmead
Berkeley
California
United-states
Tim-kelly
Sundar-jagannath
Sriram-krishnaswami
Kenneth-micklethwaite
Margarita-louis-dreyfus

Caribou Biosciences Appoints Tim Kelly as Chief Technology

Tim Kelly to lead Caribou’s technical operations strategy and execution CB-010 ANTLER Phase 1 trial initial dose expansion data and RP2D to be.

Berkeley
California
United-states
Sydney
New-south-wales
Australia
Westmead
Peggy-vorwald
Sundar-jagannath
Sriram-krishnaswami
Stephen-schuster
Kenneth-micklethwaite

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.